Serum fetuin-A levels link inflammation and cardiovascular calcification in hemodialysis patients

Mario Cozzolino1, Andrea Galassi, Maria Luisa Biondi

  • 1Renal Division, S. Paolo Hospital, University of Milan, Milan, Italy. mariocozzolino@hotmail.com

Insights

Reduced fetuin-A levels are linked to widespread cardiovascular calcifications (CVC) in hemodialysis (HD) patients. Lower fetuin-A indicates a higher risk of CVC, independent of other risk factors.

Area of Science:

  • Nephrology
  • Cardiology
  • Biochemistry

Background:

  • Cardiovascular disease (CVD) is the primary cause of death in hemodialysis (HD) patients.
  • Cardiovascular calcifications (CVC) are prevalent in HD patients and linked to inflammation and mortality.
  • Fetuin-A is a key inhibitor of CVC, and its reduced levels correlate with increased cardiovascular risk.

Purpose of the Study:

  • To investigate the association between serum fetuin-A levels and the extent of CVC in hemodialysis patients.
  • To determine if fetuin-A levels predict CVC independently of traditional cardiovascular risk factors.

Main Methods:

  • A cohort of 115 hemodialysis patients (vintage >or=9 months) was evaluated.
  • Cardiovascular calcifications (CVC) were assessed using ultrasound imaging across multiple sites, quantified as a Cardiovascular Calcification Score (CVCS).
  • Patients were stratified into groups based on CVCS (0, <6, and >=6). Serum fetuin-A, C-reactive protein, and fibrinogen levels were measured.

Main Results:

  • Patients with CVC in more than 5 sites had significantly lower serum fetuin-A levels compared to those without CVC (p=0.048).
  • A higher CVCS was associated with elevated C-reactive protein (p=0.002) and fibrinogen (p<0.001).
  • Serum fetuin-A levels below 0.290 g/l were independently associated with a higher risk of a worse CVCS.

Conclusions:

  • Chronic inflammation in hemodialysis patients contributes to reduced serum fetuin-A levels.
  • This study confirms a significant, independent association between lower serum fetuin-A levels and multi-site CVC in hemodialysis patients.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...